Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Malignant Endocrine Neoplasm — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Malignant Endocrine Neoplasm

Cancer Family

Malignant Endocrine Neoplasm

CI-CAN-00000230Explore in graph →

576 active trials16 approved drugs58 evidence items

NCIt: C3575

Overview
Statistics
Survival
Genomics13
Variants & evidence58
Drugs22
Trials1801
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

1,801 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 576
Recruiting: 291
Ph III recruiting: 33
Growth YoY: +2.2%
Industry share: 34%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (238)

StatusAll Active (any)Completed 584 Recruiting 365 Unknown 250 Terminated 200 Active Not Recruiting 186 Not Yet Recruiting 135 Withdrawn 46 Enrolling By Invitation 13 Approved For Marketing 7 Suspended 7 No Longer Available 4 Available 4

PhaseAll Early Phase 1 14 N/A 160 Phase 1 486 Phase 2 909 Phase 3 159 Phase 4 16

No study matches these filters